Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases

Accounts of Chemical Research

Volumn 42, Issue 3, 2009, Pages 439-451

  Silverman, Richard B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; NEURONAL NITRIC OXIDE SYNTHASE;

ANIMAL; ARTICLE; CHEMISTRY; DEGENERATIVE DISEASE; DRUG ANTAGONISM; DRUG DESIGN; ENZYMOLOGY; HUMAN; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY; ANTAGONISTS AND INHIBITORS; NEURODEGENERATIVE DISEASES;

ANIMALS; CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; ENZYME INHIBITORS; HUMANS; NEURODEGENERATIVE DISEASES; NITRIC OXIDE SYNTHASE TYPE I; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 65249163408     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar800201v     Document Type: Article

References (61)

1. (a) Li, H.; Poulos, T. L. Structure-function studies on nitric oxide synthases. J. Inorg. Biochem. 2005, 99 (1), 293-305.
2. (b) Fleming, I. Biology of nitric oxide synthases. In Handbook of Physiology: Microcirculation, 2nd ed.; Tuma, R. F., Duran, W. N., Ley, K., Eds.; Elsevier: San Diego, CA, 2008; pp 56-80.
3. (a) Huang, P. L.; Huang, Z.; Mashimo, H.; Bloch, K. D.; Moskowitz, M. A.; Bevan, J. A.; Fishman, M. C. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995, 377, 239.
4. (b) Wei, X. Q.; Charles, I. G.; Smith, A.; Ure, J.; Feng, G. J.; Huang, F. P.; Xu, D.; Muller, W.; Moncada, S.; Liew, F. Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995, 375, 408.
5. (c) Ferriero, D. M.; Holtzman, D. M.; Black, S. M.; Sheldon, R. A. Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol. Dis. 1996, 3, 64-71.
6. Erdal, E. P.; Litzinger, E. A.; Seo, J.; Zhu, Y.; Ji, H.; Silverman, R. B. Selective neuronal nitric oxide synthase inhibitors. Curr. Top. Med. Chem. 2005, 5, 603-624.
7. G- nitroarginine. Biochemistry 1993, 32, 8512-8517.
8. G-nitro-L-arginine on the blood pressure of spontaneously hypertensive rats with different degrees of hypertension. Clin. Exp. Hypertens. 2001, 23 (7), 533-544.
9. (a) lyengar, R.; Stuehr, D. J.; Marietta, M. A. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc. Natl Acad. Sci. U.S.A. 1987, 84, 6369-6373.
10. (b) Hecker, M.; Walsh, D. T.; Vane, J. R. On the substrate specificity of nitric oxide synthase. FEBS Lett. 1991, 294, 221-4
11. ω- nitroarginine- and phenylalanine-containing dipeptides and dipeptide esters. J. Med. Chem. 1997, 40, 2813-2817.
12. ω-nitroarginine-containing dipeptide amides. Potent and highly selective inhibitors of neuronal nitric oxide synthase. J. Med. Chem. 1999, 42, 3147-3153.
13. ω -nitroarginine-containing dipeptide amides to neuronal nitric oxide synthase. J. Am. Chem. Soc. 2000, 122, 7869-7875.
14. ω- nitroarginine and D-2,4-diaminobutyric acid as inhibitors of neuronal nitric oxide synthase. J. Enzyme Inhib. 2001, 16, 233-239.
15. Huang, H.; Martásek, P.; Roman, L. J.; Silverman, R. B. Synthesis and evaluation of peptidomimetics as selective inhibitors and active site probes of nitric oxide synthases. J. Med. Chem. 2000, 43, 2938-2945.
16. Seo, J.; Martásek, P.; Roman, L. J.; Silverman, R. B. Selective l-nitroargininylaminopyrrolidine and L-nitroargininylaminopiperidine neuronal nitric oxide synthase inhibitors. Bioorg. Med. Chem. 2007, 15,1928-1938.
17. Roach, T.; Silverman, R. B. Unpublished results.
18. Gómez-Vidal, J. A.; Martásek, P.; Roman, L. J.; Silverman, R. B. Potent and selective conformationally-restricted neuronal nitric oxide synthase inhibitors. J. Med. Chem. 2004, 47, 703-710.
19. (a) Gómez-Vidal, J. A.; Silverman, R. B. Short, highly efficient syntheses of 3-azido-and 4-azidoproline derivatives and their precursors. Org Lett. 2001, 3, 2481-2484.
20. (b) Gómez-Vidal, J. A.; Forrester, M. T.; Silverman, R. B. Mild and selective sodium azide-mediated cleavage of p-nitrobenzoic esters. Org. Lett. 2001, 3, 2477-2479.
21. Ji, H.; Gómez-Vidal, J. A.; Martásek, P.; J. Roman, L. J.; Silverman, R. B. Conformationally-restricted dipeptide amides as potent and selective neuronal nitric oxide synthase inhibitors. J. Med. Chem. 2006, 49, 6254-6263.
22. Mbadugha, B. N. A.; Seo, J.; Ji, H.; Martásek, P.; Roman, L J.; Shea, T. M.; Silverman, R. B. Hydroxyl-terminated peptidomimetic inhibitors of neuronal nitric oxide synthase. Bioorg. Med. Chem. 2006, 14, 3681-3690.
23. Hah, J.-M.; Roman, L. J.; Martásek, P.; Silverman, R. B. Reduced amide bond isosteric peptidomimetics. (4S)-N-(4-Amino-5-[aminoalkyl] aminopentyl)-/V-nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase. J. Med. Chem. 2001, 44, 2667-2670.
24. Hah, J.-M.; Martásek, P.; Roman, L. J.; Silverman, R. B. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase. J. Med. Chem. 2003, 46,1661-1669.
25. Wiley, R. A.; Rich, D. H. Peptidomimetics derived from natural products. Med. Res. Rev. 1993, 13, 327.
26. Erdal, E. P.; Martásek, P.; Linda, J.; Roman, L. J.; Silverman, R. B. Hydroxyethylene isosteres of selective neuronal nitric oxide synthase inhibitors. Bioorg. Med. Chem. 2007, 75,6096-6108.
27. (a) Crane, B. R.; Arvai, A. S.; Gachhhui, R.; Wu, C.; Ghosh, D. K.; Getzoff, E. D.; Steuhr, D. J.; Tainer, J. A. The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science 1997, 278 (5337), 425-431.
28. (b) Crane, B. R.; Arvai, A. S.; Ghosh, D. K.; Wu, C.; Getzoff, E. D.; Stuehr, D. J.; Tainer, J. A. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 1998, 279 (5359), 2121-2126.
29. Raman, C. S.; Li, H.; Martasek, P.; Krai, V.; Masters, B. S. S.; Poulos, T. L. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Ce// 1998, 95 (7), 939-950.
30. Fischmann, T. 0.; Hruza, A.; Niu, X. D.; Fossetta, J. D.; Lunn, C. A.; Dolphin, E.; Prongay, A. J.; Reichert, P.; Lundell, D. J.; Narula, S. K.; Weber, P. C. Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat. Struct. Biol. 1999, 6 (3), 233-242.
31. (a) Li, H.; Shimizu, H.; Flinspach, M.; Jamal, J.; Yang, W.; Xian, M.; Cai, T.; Wen, E. Z.; Jia, Q.; Wang, P. G.; Poulos, T. L. The novel binding mode of N-alkyl-N-hydroxyguanidine to neuronal nitric oxide synthase provides mechanistic insights into NO biosynthesis. Biochemistry 2002, 41 (47), 13868-13875.
32. (b) Bretscher, L. E.; Li, H.; Poulos, T. L.; Griffith, 0. W. Structural characterization and kinetics of nitric-oxide synthase inhibition by novel N5-(iminoalkyl)- and N5-(iminoalkenyl)-ornithines. J. Biol. Chem. 2003, 278 (47), 46789-46797.
33. Flinspach, M.; Li, H.; Jamal, J.; Yang, W.; Huang, H.; Hah, J.-M.; Gomez-Vidal, J. A.; Litzinger, E. A.; Silverman, R. B.; Poulos, T. L. Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase. Nat. Struct. Mol. Biol. 2004, 11,54-59.
34. (a) Li, H.; Raman, C. S.; Martasek, P.; Krai, V.; Masters, B. S. S.; Poulos, T. L. Mapping the active site polarity in structures of endothelial nitric oxide synthase heme domain complexed with isothioureas. J. Inorg. Biochem. 2000, 81,133-139.
35. (b) Li, H.; Raman, C. S.; Martasek, P.; Masters, B. S. S.; Poulos, T. L. Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors. Biochemistry 2001, 40, 5399-5406.
36. Li, H.; Flinspach, M. L.; Igarashi, J.; Jamal, J.; Yang, W.; Gómez-Vidal, J. A.; Litzinger, E. A.; Huang, H.; Erdal, E. P.; Silverman, R. B.; Poulos, T. P. Exploring the binding conformations of bulkier dipeptide amide inhibitors in constitutive nitric oxide synthases. Biochemistry' 2005, 44,15222-15229.
37. Flinspach, M.; Li, H.; Jamal, J.; Yang, W.; Huang, H.; Silverman, R. B.; Poulos, T. L. Structures of the neuronal and endothelial NOS heme domain with D-nitroarginine-containing dipeptide inhibitors bound. Biochemistry 2004, 43, 5181-5187.
38. ω-nitro-L-arginine-containing peptidomimetics as selective inhibitors of neuronal nitric oxide synthase. Displacement of the heme structural water. J. Med. Chem. 2007, 50, 2089-2099.
39. Ji, H.; Li, H.; Flinspach, M.; Poulos, T. L.; Silverman, R. B. Computer modeling of selective regions in the active site of nitric oxide synthases: Implication for the design of isoform-selective inhibitors. J. Med. Chem. 2003, 46, 5700-5711.
40. GRID, version 20; Molecular Discovery, Ltd., 4 Chandos Street, London, U.K., 2002.
41. (a) GOLPE 4.5, Multivariate Informetric Analysis Sri., Viale del Castagni 16, Perugia, Italy, 1999.
42. (b) Westerhuis, J. A.; Kourti, T.; Macgregor, J. F. Analysis of multiblock and hierarchical PCA and PLS models. J. Chemom. 1998, 72, 301-321.
43. Ji, H.; Stanton, B. Z.; Igarashi, J.; Li, H.; Martásek, P.; Roman, L. J.; Poulos, T. L.; Silverman, R. B. Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors. J. Am. Chem. Soc. 2008, 130 (12), 3900-3914.
44. Ji, H.; Li, H.; Martásek, P.; Roman, L. J.; Poulos, T. L.; Silverman, R. B. Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping. J. Med. Chem. 2009, 52, ASAP; DOI: 10.1021/jm801220a.
45. Ji, H.; Tan, S.; Igarashi, J.; Li, H.; Derrick, M.; Martásek, P.; Roman, L. J.; Vásquez-Vivar, J.; Poulos, T. L.; Silverman, R. B. Selective neuronal nitric oxide synthase inhibitors for prevention of cerebral palsy. Ann. Neurol., in press.
46. Ji, H.; Silverman, R. B. Unpublished results.
47. Garcin, E. D.; Arvai, A. S.; Rosenfeld, R. J.; Kroeger, M. D.; Crane, B. R.; Andersson, G.; Andrews, G.; Hamley, P. J.; Mallinder, P. R.; Nicholls, D. J.; St-Gallay, S. A.; Tinker, A. C.; Gensmantel, N. P.; Mete, A.; Cheshire, D. R.; Connolly, S.; Stuehr, D. J.; Aberg, A.; Wallace, A. V.; Tainer, J. A.; Getzoff, E. D. Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase. Nat. Chem. Biol. 2008, 4(11), 700-707.
48. Collins, J. L.; Shearer, B. G.; Oplinger, J. A.; Lee, S.; Garvey, E. P.; Salter, M.; Duffy, C.; Burnette, T. C.; Furfine, E. S. N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: Structure - activity studies and demonstration of in vivo activity. J. Med. Chem. 1998, 41 (15), 2858-2871.
49. ω-propyl-L-Arg for the inducible and neuronal isoforms. J. Biol. Chem. 2003, 278(46), 45818-45825.
50. Li, H.; Raman, C. S.; Martásek, P.; Masters, B. S.; Poulos, T. L. Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors. Biochemistry 2001, 40(18), 5399-5406.
51. (a) Zhu, Y.; Nikolic, D.; Van Breemen, R. B.; Silverman, R. B. Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification. J. Am. Chem. Soc. 2005, 127(3), 858-868.
52. (b) Garvey, E. P.; Oplinger, J. A.; Furfine, E. S.; Kiff, R. J.; Laszlo, F.; Whittle, B. J.; Knowles, R. G. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 1997, 272(8), 4959-4963.
53. (a) Derrick, M.; He, J.; Brady, E.; Tan, S. The in vitro fate of rabbit fetal brain cells after acute in vivo hypoxia. J. Neurosci. 2001, 27(7), RC138/1-RC138/5.
54. (b) Tan, S.; Zhou, F.; Nielsen, V. G.; Wang, Z.; Gladson, C. L.; Parks, D. A. Increased injury following intermittent fetal hypoxia-reoxygenation is associated with increased free radical production in fetal rabbit brain. J. Neuropathol. Exp. Neurol. 1999, 58(9), 972-981.
55. Tan, S.; Derrick, M.; Ji, H.; Silverman, R. B. Unpublished results.
56. (a) Derrick, M.; Luo, N. L.; Bregman, J. C.; Ji Ming, T.; Ji, X.; Fisher, K.; Gladson, C. L.; Beardsley, D. J.; Murdoch, G.; Back, S. A.; Tan, S. J. Neurosci. 2004, 24, 24-34.
57. (b) Tan, S.; Drobyshevsky, A.; Jilling, T.; Ji, X.; Ullman, L. M.; Englof, I.; Derrick, M. J. Child Neurol. 2005, 20, 972-979.
58. (c) Derrick, M.; Drobyshevsky, A.; Ji, X.; Tan, S. A model of cerebral palsy from fetal hypoxia-ischemia. Stroke 2007, 38(2 Suppl), 731-735.
59. Robinson, S.; Petelenz, K.; Li, Q.; Cohen, M. L.; DeChant, A.; Tabrizi, N.; Bucek, M.; Lust, D.; Miller, R. H. Developmental changes induced by graded prenatal systemic hypoxic-ischemic insults in rats. Neurobiol. Dis 2005, 18(3), 568-581.
60. Winter, S.; Autry, A.; Boyle, C.; Yeargin-Allsopp, M. Trends in the prevalence of cerebral palsy in a population-based study. Pediatrics 2002, 110, 1220-1225.
61. Tyson, J. E.; Gilstrap, L. C. Hope for perinatal prevention of cerebral palsy. JAMA, J. Am. Med. Assoc. 2003, 290, 2730-2732.